Pediatric anesthesia & critical care

Child's Temperament as Risk Factor for Preoperative Anxiety—A Secondary Analysis of the ALPAKA Trial

Paediatr AnaesthPublished Secondary analysis of the ALPAKA randomised trial

Authors' conclusion

Behavioral inhibition is a robust predictor of perioperative anxiety in young children, both before and after midazolam administration.

Study context

Population
Children aged 2–8 years undergoing elective surgeryincluded in final analysis
Participants
89 children
Comparison
Association of temperament traits with preoperative anxiety before (T1) and after (T2) midazolam
Primary endpoint
Preoperative anxiety (modified Yale Preoperative Anxiety Scale-Short Form (mYPAS-SF); elevated anxiety mYPAS-SF > 30) and its association with temperament (Integrative Child Temperament Inventory (ICTI))
Follow-up
Before (T1) and after (T2) midazolam administration

Primary result

As reported in the abstract

Behavioral inhibition vs anxiety (Spearman correlation)

Behavioral inhibition associated with anxiety at T1: rs, 95% CI 0.15-0.53, p = 0.001

0.35

Behavioral inhibition associated with anxiety at T2: rs, 95% CI 0.28-0.62, p < 0.001

0.46

Further findings

Predictors of elevated anxiety at T1 (logistic regression)

OR (95% CI)P value
Male sexIndependently associated3.16 (1.36–7.19)P = 0.011
Prior anesthesia experienceIndependently associated4.28 (1.78–10.39)P = 0.001

Behavioral inhibition and elevated anxiety, adjusted for sex and prior anesthesia (multivariable logistic regression) · T1

OR (95% CI)
Behavioral inhibitionAdjusted by sex and prior anesthesia1.02 (1.00–1.05)
For T2, corresponding model showed limited explanatory power

Original publication

Child's Temperament as Risk Factor for Preoperative Anxiety—A Secondary Analysis of the ALPAKA Trial. Paediatr Anaesth. Published 18 February 2026. doi:10.1002/pan.70150

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.